Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer

SAN DIEGO--(BUSINESS WIRE)--Truvian Health (“Truvian”), a transformational diagnostics company redefining healthcare, today announced the appointment of Michael J. Mina, MD, PhD, as Chief Medical and Strategy Officer. Dr. Mina, a former Harvard professor and a globally recognized leader in epidemiology and diagnostic technology, joins Truvian as the company accelerates its mission to decentralize blood testing following the recent FDA clearance of its TruVerus™, a multimodal blood analyzer.

In his new role with Truvian, Dr. Mina will oversee clinical and regulatory strategy, while advancing strategic partnerships and opportunities across the biomedical and technology sector to accelerate Truvian’s market adoption and growth.

Dr. Mina’s career has been defined by his work at the intersection of immunology, diagnostics, bioengineering, and public health. A former professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School, his research has fundamentally shaped aspects of our modern understanding of the role diagnostics play in disease prevention and health system innovation. During the COVID-19 pandemic, Dr. Mina emerged as a leading global voice on testing strategy, advising governments and industry leaders on how to use technology to build more resilient health systems.

"We are entering a pivotal chapter at Truvian as we move toward commercialization of the TruVerus platform," said Dena Marrinucci, PhD, Co-Founder and Chief Operating Officer of Truvian. "Dr. Mina’s unique perspective as both a clinician and a technologist is a perfect match for our culture of rigorous science and accessibility. His track record of bridging the gap between academic discovery and practical, large-scale deployment will be invaluable as we work to place lab-quality diagnostics directly into the hands of healthcare providers wherever care happens."

Prior to joining Truvian, Dr. Mina served as the associate director of molecular diagnostics at Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard. In addition to his clinical and academic contributions, he is a seasoned entrepreneur, having helped lead and exit numerous biotechnology companies and is a lecturer at the M.I.T. Sloan School of Management. His expertise in commercializing next-generation diagnostic technologies, including digital health platforms that link testing with telemedicine, aligns with Truvian’s mission to decentralize the traditional lab model.

"Truvian is doing what many thought was impossible: miniaturizing and automating the gold-standard of lab testing without compromising on accuracy," said Dr. Mina. "Throughout my career, I have advocated for diagnostics that are not just precise, but also more accessible to more people and that can offer results when we need them most – at the point of care. Truvian is doing just that and I am thrilled to join Dena and the entire Truvian team to help realize a future where diagnostic data empowers providers to deliver faster, more informed care with results available in minutes, all towards building a more resilient healthcare system.”

About Truvian

Truvian Health is a transformational diagnostics company redefining healthcare through its FDA-cleared, multimodal blood testing platform. Built on a foundation of scientific integrity and relentless innovation, Truvian empowers providers and patients with convenient, accurate, timely, and comprehensive testing – without compromise. Truvian’s expanding portfolio of assays delivers central lab‑quality results available to anyone, anywhere. Learn more at truvianhealth.com or follow us on LinkedIn.

Disclaimer:

This press release contains forward‑looking statements based on current expectations and plans. These statements involve risks and uncertainties that could cause actual results to differ from what we expect. We do not promise to update any forward‑looking statements to reflect future events.

Media Contact:
Katherine Atkinson
katherine.c.atkinson@truvianhealth.com

For press inquiries and interview requests, please email us at media@truvianhealth.com.